Financing, Equity Capital Markets
Immunic, Inc.
07/21
|
$45.0 Million
Âé¶¹´«Ã½ served as sole bookrunner for Immunic, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma